- Presentations
- 3
- Markets
- 1
Scemblix is a brand of Asciminib marketed by Novartis Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Asciminib
- Brand owner
- Novartis Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 100 mg tablet, 20 mg tablet, 40 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Scemblix 100 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Scemblix 20 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Scemblix 40 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Scemblix
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.